Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats
Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats
复制标题
DOI:
10.1161/01.str.28.5.1060
复制
发表时间:
1997-05-01
期刊:
影响因子:
8.3
通讯作者:
Fisher, M
中科院分区:
文献类型:
--
作者:
Onal, MZ;Li, FH;Fisher, M
Background and Purpose Citicoline, a naturally occurring precursor of phosphatidylcholine, is neuroprotective and is currently being assessed in clinical trials. To evaluate potential synergistic neuroprotective effects of prolonged citicoline treatment and early N-methyl-D-aspartate (NMDA) antagonist therapy, suboptimal treatment regimens of citicoline and MK-801 were tested alone and in combination in a rat model of temporary focal ischemia.Methods Four groups of Sprague-Dawley rats (n=12 per group) underwent 90 minutes of temporary middle cerebral artery occlusion (MCAO) with the suture model. Animals were randomly and blindly assigned to one of four treatment groups: (1) saline, vehicle; (2) MK-801, 0.5 mg/kg IV bolus at 60 minutes after MCAO followed by saline 1 mL/kg IP daily for 7 days; (3) saline IV at 60 minutes after MCAO followed by citicoline 250 mg/kg IP daily for 7 days; or (4) both MK-801 and citicoline (daily for 7 days) active treatment. Triphenyltetrazolium chloride staining was used to assess postmortem infarct volume. Neurological scores were determined daily.Results Premature mortality between days 2 and 4 was 33.3% in group 1, 41.7% in groups 2 and 3, and 25.0% in group 4. Mean corrected infarct volume was significantly reduced in group 4 compared with the others (175.2+/-89.3 mm(3) in group 1, 179.1+/-78.5 mm(3) in group 2, 163.9+/-73.7 mm(3) in group 3, and 84.7+/-56.8 mm(3) in group 4 [P